A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01248702

Acronym

CAPTURE

Enrollment

600

Registered

2010-11-25

Start date

2012-04-30

Completion date

2012-05-31

Last updated

2012-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Myocardial Infarction

Keywords

Myocardial Infarction, Heart Failure, Sudden Cardiac Death, Critical Pathways

Brief summary

The purpose of this study is to develop and implement a critical pathway to identify patients with ischemic cardiomyopathy who are candidates for an implantable cardioverter-defibrillator (ICD). This study will also determine whether the use of the critical pathway for ICDs is associated with a change in the ICD referral and implantation rate.

Detailed description

Despite improvements in both medical management and revascularization strategies, sudden death is still a significant complication in patients with ischemic cardiomyopathy. There is strong evidence to support the role of ICDs for the primary prevention of sudden death in this population. However, in Canada and the United States, ICDs are underutilized. Critical pathways are algorithms that improve health care delivery and clinical outcomes while reducing practice variability. The use of a critical pathway to assess a patient's eligibility for an ICD may increase the appropriate use of this evidence-based technology.

Interventions

OTHERUse of the ICD Critical Pathway

The critical pathway is a series of predetermined processes designed to assess a patient's eligibility for an ICD. The critical pathway will incorporate current evidence-based practice guidelines.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* acute ST segment elevation myocardial infarction (STEMI) * candidate for percutaneous revascularization * permanent residents of British Columbia, Canada

Exclusion criteria

* patients with heart disease or a comorbid illness who have a documented life expectancy of less than 1 year

Design outcomes

Primary

Measure	Time frame
Rate of Referral for ICD Assessment	1 year

Secondary

Measure	Time frame
Rate of ICD Implantation	1 year

Countries

Canada

Contacts

Primary ContactS Cowan, MD, MSc

capture.study@gmail.com(604) 682 2344

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026